The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results
Open accessAbstract
BACKGROUND: Fluorescence-guided surgery (FGS) is a technique used to enhance visualization of tumor margins in order to increase the extent of tumor resection in glioma surgery. In this paper, we systematically review all clinically tested fluorescent agents for application in FGS for glioma and all preclinically tested agents with the potential for FGS for glioma. METHODS: We searched the PubMed and Embase databases for all potentially relevant studies through March 2016. We assessed fluorescent agents by the following outcomes: rate of gross total resection (GTR), overall and progression-free survival, sensitivity and specificity in discriminating tumor and healthy brain tissue, tumor-to-normal ratio of fluorescent signal, and incidence of adverse events. RESULTS: The search strategy resulted in 2155 articles that were screened by titles and abstracts. After full-text screening, 105 articles fulfilled the inclusion criteria evaluating the following fluorescent agents: 5-aminolevulinic acid (5-ALA) (44 studies, including three randomized control trials), fluorescein (11), indocyanine green (five), hypericin (two), 5-aminofluorescein-human serum albumin (one), endogenous fluorophores (nine) and fluorescent agents in a pre-clinical testing phase (30). Three meta-analyses were also identified. CONCLUSIONS: 5-ALA is the only fluorescent agent that has been tested in a randomized controlled trial and results in an improvement of GTR and progression-free survival in high-grade gliomas. Observational cohort studies and case series suggest similar outcomes for FGS using fluorescein. Molecular targeting agents (e.g., fluorophore/nanoparticle labeled with anti-EGFR antibodies) are still in the pre-clinical phase, but offer promising results and may be valuable future alternatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423 · cited 24×
“For the purpose of this review, we chose the rate of GTR, PFS, overall survival, and histological accuracy (sensitivity, specificity, TNR) as outcome measures, because these are the most frequently reported outcome measures among these studies.”
BackgroundMethodResultInfluentialA small-molecule dye for NIR-II imaging
Antaris, A. L., Chen, H., Cheng, K., Sun, Y., Hong, G., Qu, C., Diao, S., Deng, Z., Hu, X., Zhang, B., et al. (2016) · Nature Materials · doi:10.1038/nmat4476 · Cited by 1,778
An overview of nanoparticles commonly used in fluorescent bioimaging
Wolfbeis, O. S. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00392f · Cited by 1,631 · cited 1×
“This nonspecific binding can modify the optical properties of the fluorophore and the function of cellular proteins [114].”
BackgroundStummer, W., Novotny, A., Stepp, H., Goetz, C., Bise, K., & Reulen, H. J. (2000) · Journal of Neurosurgery · doi:10.3171/jns.2000.93.6.1003 · Cited by 881 · cited 3×
“For discriminating glioblastoma multiforme (GBM) tissue from healthy brain tissue, the sensitivity and specificity ranged from 70 to 95% and 43 to 100%, respectively [25, 34, 74, 98].”
BackgroundShinoda, J., Yano, H., Yoshimura, S.-I., Okumura, A., Kaku, Y., Iwama, T., & Sakai, N. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.3.0597 · Cited by 249
Cited by
5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas
Mahmoudi, K., Garvey, K. L., Bouras, A., Cramer, G., Stepp, H., Jesu Raj, J. G., Bozec, D., Busch, T. M., & Hadjipanayis, C. G. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03103-4 · Cited by 292
Advances in Brain Tumor Surgery for Glioblastoma in Adults
Lara-Velazquez, M., Al-Kharboosh, R., Jeanneret, S., Vazquez-Ramos, C., Mahato, D., Tavanaiepour, D., Rahmathulla, G., & Quinones-Hinojosa, A. (2017) · Brain Sciences · doi:10.3390/brainsci7120166 · Cited by 285
Schupper, A. J., Baron, R. B., Cheung, W., Rodriguez, J., Kalkanis, S. N., Chohan, M. O., Andersen, B. J., Chamoun, R., Nahed, B. V., Zacharia, B. E., et al. (2022) · Journal of Neurosurgery · doi:10.3171/2021.5.jns21310 · Cited by 59
Metadata
- Authors
- Senders, J. T., Muskens, I. S., Schnoor, R., Karhade, A. V., Cote, D. J., Smith, T. R., & Broekman, M. L. D.
- Venue
- Acta Neurochirurgica
- Published
- 2016-11-22
- Volume
- 159
- Issue
- 1
- Pages
- 151-167
- ISSN
- 0001-6268 (ISSN-L)
- 0942-0940
- OpenAlex
- W2554584625
- Cited by
- 161
- References
- 5
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.